Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 2Pain 1Osteoporosis 1Neoplasm Metastasis 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Radiotherapy 31Carboplatin 29Cisplatin 28Paclitaxel 26Gemcitabine 14Docetaxel 14Etoposide 13Bevacizumab 9Ramucirumab 7Pemetrexed 6Magnetic Resonance Spectroscopy 5Erlotinib Hydrochloride 5Cetuximab 5pembrolizumab 4cediranib 4Vinorelbine 4Specimen Handling 4Radiosurgery 4Gene Expression Profiling 4Filgrastim 4Amplified Fragment Length Polymorphism Analysis 4dexamethasone acetate 3dexamethasone 21-phosphate 3auricularum 3Surgical Procedures, Operative 3Radiotherapy, Conformal 3Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Neoadjuvant Therapy 3Irinotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lung Neoplasms × Calcium × Clear all
NCT00365105 2024-09-20

Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
261 enrolled 12 charts
BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡